A concise summary detailing what this focus area is, why it matters, and who it is designed to help.
Functional Foods & Bioactives
De-risk functional food and ingredient decisions with credible endpoints—combining evidence synthesis, fit-for-purpose study planning, and real-world validation.
Overview
Functional foods and bioactives succeed when the evidence pathway is clear: relevant endpoints, credible effects, and communication that stays within what the science supports. We help organizations evaluate the existing evidence, design fit-for-purpose studies, and plan real-world learning—so product decisions are de-risked and stakeholder trust is protected. The emphasis is on measurable benefits, transparent interpretation, and responsible positioning.
Solutions Used
A list of methods and capabilities utilized to execute the work and achieve the objectives within this focus area.
- Commercial Innovation (Foods & Supplements) — To guide evidence-led product and portfolio decisions, including opportunity and evidence roadmapping.
- Evidence Synthesis & Guidelines — To assess the strength, consistency, and relevance of the ingredient/bioactive evidence base.
- Study Protocols & Trial Design — To design studies aligned to intended benefits, populations, and endpoints.
- Data Science & Statistics — To deliver interpretable estimates with uncertainty, sensitivity checks, and reproducible workflows.
- Claims Substantiation & Regulatory Strategy — To support defensible claim strategy, documentation, wording, and guardrails.
- Real-World Evidence (RWE) Strategy & Post-Market Evaluation — To plan post-launch validation, monitoring, and learning in real settings.
Key Measures
The specific clinical, economic, and programmatic indicators we track to quantify success and validate impact.
Depending on the question and setting, key measures may include:
- Benefit-aligned Endpoints: cardiometabolic, glycemic, inflammatory, satiety/appetite, GI symptom, or other outcomes matched to intended benefit.
- Mechanistic/Biomarker Support: pathway markers that strengthen interpretation without overstating causality.
- Safety & Tolerability: adverse events, discontinuation, contraindications (context-dependent).
- Dose/Exposure & Adherence: dose/formulation, compliance, real-world use patterns.
- Population Relevance: subgroup response and heterogeneity across intended user segments.
- Evidence Robustness: risk-of-bias considerations, uncertainty, consistency, sensitivity analyses.
- Post-market Performance: continued use, user-reported benefit signals (as appropriate), and monitoring KPIs.
Related Focus Areas
Complementary health domains, populations, and settings that frequently intersect with this area of expertise.
